(Q35792816)

English

A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.

scientific article published on 9 December 2009

Statements

A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit